(Q37932864)

25 August 2017

1 reference

title

Corticosteroids in respiratory diseases in children. (English)

1 reference

25 August 2017

author name string

Fernando M de Benedictis

series ordinal

1

1 reference

25 August 2017

Andrew Bush

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

American Journal of Respiratory and Critical Care Medicine

25 August 2017

published in

1 reference

25 August 2017

volume

185

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

12-23

1 reference

The role of corticosteroids in respiratory diseases of children

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Nongenomic actions of glucocorticosteroids on the airway vasculature in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Mechanisms of glucocorticoid action in pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Regulation of inflammatory cell function by corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

The molecular mechanisms of glucocorticoids-mediated neutrophil survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Corticosteroid inhibition of airway microvascular leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Effect of dexamethasone and ACC on bacteria-induced mucin expression in human airway mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Exercise-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Glucocorticoid therapy for asthma: clinical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Inhaled glucocorticoids for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Long-term effects of budesonide or nedocromil in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Changes of exhaled nitric oxide during steroid treatment of childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Leukotriene antagonists as first-line or add-on asthma-controller therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Comparison of inhaled corticosteroids: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Dose response of inhaled corticosteroids in children with persistent asthma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Prednisolone and salbutamol in the hospital treatment of acute asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Selecting a systemic corticosteroid for acute asthma in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Parent initiated prednisolone for acute asthma in children of school age: randomised controlled crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Corticosteroids in Acute Asthma: Past, Present, and Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Managing acute pediatric asthma: keeping it short

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

The use of inhaled corticosteroids in the wheezy under 5-year-old child

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Oral prednisolone for preschool children with acute virus-induced wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Children and the risk of fractures caused by oral corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Controversies in the management of preschool viral wheeze

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Preemptive use of high-dose fluticasone for virus-induced wheezing in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Medicines used in respiratory diseases only seen in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Anti-inflammatory pharmacotherapy for wheezing in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Diagnosis and management of bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Epinephrine and dexamethasone in children with bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Cost-effectiveness of epinephrine and dexamethasone in children with bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

21 January 2018

Clinical practice. Croup

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

The effectiveness of glucocorticoids in treating croup: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Nebulized Budesonide and Oral Dexamethasone for Treatment of Croup

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Prednisolone versus dexamethasone in croup: a randomised equivalence trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

The new bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Minidex: very low dose dexamethasone (0.05 mg/kg/day) in chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

The Neonatal European Study of Inhaled Steroids (NEUROSIS): an eu-funded international randomised controlled trial in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

The role of inflammation in the pathophysiology of CF lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Anti-inflammatory approaches to cystic fibrosis airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

The role of inhaled corticosteroids in the management of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Bolus methylprednisolone efficacy for uncontrolled exacerbation of cystic fibrosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Central nervous system aspergillosis following steroidal therapy for allergic bronchopulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Primary ciliary dyskinesia: current state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Characteristics of disorders associated with genetic mutations of surfactant protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Corticosteroids to prevent postextubation upper airway obstruction: the evidence mounts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

21 January 2018

Subglottic hemangioma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Treatment of congenital subglottic hemangiomas: our experience compared with reports in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Propranolol for the treatment of airway hemangiomas: A case series and treatment algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Steroids for intubated croup masking airway haemangioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Pediatric acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

21 January 2018

Aspiration lung disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Intermittent Inhaled Corticosteroids in Infants with Episodic Wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Allergic Bronchopulmonary Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Double-blind trial of steroid tapering in acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Effects of omalizumab in Aspergillus-associated airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201107-1174CI

Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD004881.PUB2

Identifiers

DOI

10.1164/RCCM.201107-1174CI

1 reference

25 August 2017

1 reference